Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | PAM | P19021 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | MGLL | Q99685 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | PRKCA | P17252 | 1/20 | 0.47 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.47 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.47 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.47 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.47 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.47 |
| ▸ | MGAM | O43451 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexane SCHEMBL8603215 | 0.98 | DGKA (0.55) | DGKACYP1A2PAMLMNAKDM4E | |
| Heptane SCHEMBL916291 | 0.98 | DGKA (0.61) | DGKACYP1A2PAMLMNAKDM4E | |
| Butyl Alcohol SCHEMBL3027167 | 0.96 | CYP1A2 (0.57) | DGKACYP1A2PAMLMNAKDM4E | |
| Hexane SCHEMBL8820869 | 0.94 | DGKA (0.52) | DGKACYP1A2PAMLMNAKDM4E | |
| Hexane SCHEMBL1752606 | 0.94 | DGKA (0.61) | DGKACYP1A2PAMLMNAKDM4E | |
| SCHEMBL6736 | 0.93 | — | — | |
| Heptane SCHEMBL1238729 | 0.92 | DGKA (0.64) | DGKACYP1A2PAMLMNAKDM4E | |
| 1-Hexanol SCHEMBL1863211 | 0.92 | DGKA (0.59) | DGKACYP1A2PAMLMNAKDM4E | |
| Decanol SCHEMBL11043200 | 0.92 | DGKA (0.64) | DGKACYP1A2PAMLMNAKDM4E | |
| Hexane SCHEMBL5393961 | 0.92 | DGKA (0.64) | DGKACYP1A2PAMLMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 375 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104280507-B | A kind of TLC Identification of arthralgia and myalgia wine | Jiangsu 707 Natural Pharmaceutical Co., Ltd. (CN) | 2016-04-13 | — | — | CN | claimed |
| CN-104280507-A | Thin-layer chromatographic identification method of wine for treating arthralgia and myalgia | Jiangsu 707 natural pharmaceutical co ltd | 2015-01-14 | — | — | CN | claimed |
| CN-101199677-B | A Chinese medicinal preparation for treating traumatic injury and rheumatic arthritis, and its preparation method | GUANGXI WANSHOUTANG DRUG INDUSTRY CO LTD | 2012-05-09 | — | — | CN | claimed |
| CN-101664489-A | Preparation method of traditional Chinese medical composition as well as quality control method thereof | SHAANXI DONGTAI PHARMACEUTICAL | 2010-03-10 | — | — | CN | claimed |
| CN-101279067-A | Preparation of shaolin plaster for rheumatism and wound and quality control method | ZHANG HUILIN (CN) | 2008-10-08 | — | — | CN | claimed |
| CN-101199677-A | Chinese medicine agent for treating injuries from falls, rheumatoid arthritis and preparing method thereof | GUANGXI WANSHOUTANG DRUG INDUS (CN) | 2008-06-18 | — | — | CN | claimed |
| CN-1857602-A | Quality control method for vatility source preparation | ZHONGHUI PHARMACEUTICAL CO LTD (CN) | 2006-11-08 | — | — | CN | claimed |
| CN-112823158-B | Process for preparing 2- [ (3R) -3-methylmorpholin-4-yl ] -4- (1-methyl-1H-pyrazol-5-yl) -8- (1H-pyrazol-5-yl) -1, 7-naphthyridine | 拜耳股份有限公司 | 2023-08-15 | — | — | CN | disclosed |
| EP-3921317-B1 | 3-AMINO-2-[2-(ACYLAMINO)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE AS CSNK1 INHIBITORS | BAYER AG (DE) | 2023-08-02 | — | — | EP | disclosed |
| EP-3841101-B1 | METHOD FOR PREPARING 2-[(3R)-3-METHYLMORPHOLIN-4-YL]-4-[1-METHYL-1H-PYRAZOL-5-YL)-8-(1H-PYRAZOL-5-YL)-1,7-NAPHTHYRIDINE | BAYER AG (DE) | 2023-05-03 | — | — | EP | disclosed |
| US-20230046077-A1 | 3-AMINO-2-[2-(ACYLAMINO)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE AS CSNK1 INHIBITORS | BAYER AKTIENGESELLSCHAFT (DE) | 2023-02-16 | — | — | US | disclosed |
| US-11529356-B2 | 2-(morpholin-4-yl)-1,7-naphthyridines | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2022-12-20 | — | — | US | disclosed |
| CN-109963836-B | Deuterium atom substituted indole carboxamide derivative, preparation method and medical application thereof | 江苏恒瑞医药股份有限公司 | 2022-11-22 | — | — | CN | disclosed |
| EP-0100158-A2 | (3-pyridinyl)heteroalkarylalkanols, alkanoic acids and esters | THE UPJOHN COMPANY (US) | 1984-02-08 | — | — | EP | disclosed |
| US-4362720-A | Synthesis of 2-amino-2-deoxyglycoses and 2-amino-2-deoxyglycosides from glycals | CHEMBIOMED LTD. (CA) | 1982-12-07 | — | — | US | disclosed |
| EP-0046769-A4 | FERMENTATION OF BILE. | COMMW SCIENT IND RES ORG (AU) | 1982-07-06 | — | — | EP | disclosed |
| EP-0046769-A1 | FERMENTATION OF BILE. | COMMW SCIENT IND RES ORG (AU) | 1982-03-10 | — | — | EP | disclosed |
| US-4308376-A | Synthesis of 2-amino-2-deoxyglycoses and 2-amino-2-deoxyglycosides from glycals | CHEMBIOMED LTD. (CA) | 1981-12-29 | — | — | US | disclosed |
| WO-1981002427-A1 | FERMENTATION OF BILE | COMMW SCIENT IND RES ORG (AU) | 1981-09-03 | — | — | WO | disclosed |
| US-4195174-A | Synthesis of 2-amino-2-deoxyglycoses and 2-amino-2-deoxyglycosides from glycals | CHEMBIOMED LTD. (CA) | 1980-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11529356-B2 | 2-(morpholin-4-yl)-1,7-naphthyridines | POLQ, CCND2, NRAS | DGKA 4051/4885CYP1A2 166/4885PAM 2178/4885 |
| US-20230046077-A1 | 3-AMINO-2-[2-(ACYLAMINO)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE AS CSNK1 INHIBITORS | CSNK1A1, CSNK1G1, CSNK1E | DGKA 442/4885CYP1A2 2582/4885PAM 4202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.